Podophyllum Resin

Summary

Podophyllum Resin (CHEMBL2108775) is an approved unknown; indicated across 1 condition including anogenital human papillomavirus infection.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Unknown
• Indications: 1 condition

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL2108775
Name	Podophyllum Resin
Type	Unknown
Max phase	4

Also known as: Podoph, Podoph co, Podophyllum resin, PODOPHYLLUM RESIN

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

1 disease in clinical trials (phase 1–3, investigational — not approved indications). Highest ChEMBL trial phase per disease; a non-cancer approved use is occasionally logged at phase 3 here.

Disease (in trials)	Phase	MONDO	EFO
anogenital human papillomavirus infection	3	MONDO:0005647	EFO:0007147

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).